The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study
ConclusionIn the adjuvant treatment of stage III CRC patients, three different 5-FU administration types in FOLFOX combination treatment can be used with similar efficiency and manageable toxicity.
Source: International Journal of Colorectal Disease - Category: Gastroenterology Source Type: research
More News: Anemia | Brain | Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Eloxatin | Gastroenterology | Neurology | Statistics | Study | Thrombocytopenia | Toxicology